Mycoplasma pneumoniae nucleic acid dete₩ ction kit (PCR-fluorescent≥♣ε probe method)

Mycoplasma pneumoniae (M. Pneumonia, MP) is tγ≠δhe pathogen of human mycoplasma pne♦∏σ"umonia. The pathological→≥↑≤ changes of mycoplasma β← ✘pneumonia are mainly interstitial pneum™≈"•onia, sometimes complicated by br≥↕↔onchial pneumonia, which is called pri₽¥≤mary atypical pneumonia. Worldwid↑δe, multiple studies have'≥→ shown that the annual MP infection rate&φ"  is 9.6% to 66.7%, the α©↑infection rate during non-epidemic perσσiod is 10% to 20%, and M≥× P accounts for more than 30% of pediatric pneumon ¶ia during epidemic period. There are ÷♣approximately 156 million children>ε←✘ with pneumonia each year, of w±≈÷hich 151 million children with pne♣δ$umonia occur in developing countries and ₽₽σ→are the leading cause of death for chil→€dren under 5 years of age, accounting ≥Ω for 19% of the total number of deaths. It is¶•♣" also the main cause of death among adults, e§×specially among the elderly.
Mainly infected by droplets, the incubati'♣↓>on period is 2 to 3 weeks, an×αφ>d the incidence is the h®♦¶​ighest among adolescents. T✘∏​↓he clinical symptoms are mild, or even asyλπ​mptomatic at all, and if there are only gener‍♥₽☆al respiratory symptoms such as headach↓↔∏‌e, sore throat, fever, cough, etc., bu≥♥↕t there have been inΩ"dividual death reports. It can happen all✔↓≈™ year round, but mostly in autumn and win ​​ter.